Application
Western blot analysis of anti-NDK8 Antibody (C-term) in HL60 cell line lysates (35ug/lane). NDK8(arrow) was detected using the purified Pab.
Application
Western blot analysis of anti-NDK8 Antibody (C-term) pre-incubated without(lane 1) and with(lane 2) blocking peptide (BP8159b) in HepG2 cell line lysate. NDK8(arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. BC = breast carcinoma; HC = hepatocarcinoma.
Application
Fluorescent confocal image of A549 cell stained with NME2 (NDKB) Antibody (C-term)(Cat#AP8159b).A549 cells were fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.1%, 10 min), then incubated with NME2 (NDKB) primary antibody (1:25, 1 h at 37℃). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:400, 50 min at 37℃).Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (7units/ml, 1 h at 37℃). Nuclei were counterstained with DAPI (blue) (10 µg/ml, 10 min). NME2 (NDKB) immunoreactivity is localized to Cytoplasm and Nucleus significantly.